China declares 'decisive victory' over COVID-19 | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

China declares ‘decisive victory’ over COVID-19

/ 10:01 AM February 17, 2023

FILE PHOTO: Italy imposes mandatory COVID-19 tests for travellers from China

FILE PHOTO: Passengers wait in a queue, after Italy has ordered coronavirus disease (COVID-19) antigen swabs and virus sequencing for all travelers coming from China, where cases are surging, at the Malpensa Airport in Milan, Italy, December 29, 2022. REUTERS/Jennifer Lorenzini

BEIJING — China’s top leaders declared a “decisive victory” over COVID-19, saying its efforts led to more than 200 million people getting medical treatment and the country having the world’s lowest fatality rate.

“With continuous efforts to optimise COVID-19 prevention and control measures since November 2022, China’s COVID-19 response has made a smooth transition in a relatively short time,” China’s Politburo Standing Committee (PSC) remarked in a meeting on Thursday.

Article continues after this advertisement

“A major decisive victory in epidemic prevention and control has been achieved.”

FEATURED STORIES

Nearly 800,000 severe cases received proper treatment, but leaders cautioned that while the epidemic situation continues to improve in China, the virus is still spreading globally and continues to mutate, according to state media.

The meeting stressed that China will increase the vaccination rate for the elderly, and strengthen the supply and production of medical goods.

Article continues after this advertisement

The PSC, China’s most powerful leadership body, urged all localities and departments to strengthen the medical service system, according to the report from Xinhua.

Article continues after this advertisement

In December, China dismantled its almost three-year strict policies following historic protests against the government’s tough anti-virus curbs. The U-turn unleashed COVID on a population of 1.4 billion that had been largely shielded from the disease since it emerged in the city of Wuhan in late 2019.

Article continues after this advertisement

Scant data from the country on deaths and hospitalisations as the surge swept across the country led many countries to implement curbs against Chinese travellers entering their countries, drawing the ire of the Chinese government.

Many countries and the World Health Organization have speculated China was underreporting deaths for months.

Article continues after this advertisement

Fears swelled that the massive migration of travellers during the Lunar New Year would lead to an explosion of cases, but the government recently said the COVID situation was at a “low level” after the holidays.

Still, the cost to keep the virus in check was staggering.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

Chinese provinces spent at least 352 billion yuan ($51.6 billion) on COVID containment in 2022, according to annual budget reports from local governments, adding strains to provincial finances in a year when economic growth slowed.

RELATED STORIES

As world in the dark on China’s COVID nightmare, PH weighs options on arrival

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

sports
usa
globalnation
globalnation
entertainment
www
business
sports
sports
globalnation
TAGS: China, COVID-19, world news

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.